Related references
Note: Only part of the references are listed.Explaining inter-individual variability in phenotype Is epigenetics up to the challenge?
Nahid Turan et al.
EPIGENETICS (2010)
Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy
B. Claes et al.
HEREDITY (2010)
Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity
Christine M. Hartford et al.
BLOOD (2009)
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia
Deepika Bhatla et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Use of Cell Lines in the Investigation of Pharmacogenetic Loci
Wei Zhang et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival
U. Mahlknecht et al.
LEUKEMIA (2009)
Detection of Gene Expression in an Individual Cell Type within a Cell Mixture Using Microarray Analysis
Penelope A. Bryant et al.
PLOS ONE (2009)
Genetic factors influencing cytarabine therapy
Jatinder K. Lamba
PHARMACOGENOMICS (2009)
Pharmacogenomic Discovery Using Cell-Based Models
M. Welsh et al.
PHARMACOLOGICAL REVIEWS (2009)
Gemcitabine and cytosine arabinoside cytotoxicity: Association with lymphoblastoid cell expression
Liang Li et al.
CANCER RESEARCH (2008)
Differential Allelic Expression in Leukoblast from Patients with Acute Myeloid Leukemia Suggests Genetic Regulation of CDA, DCK, NT5C2, NT5C3, and TP53
L. P. Jordheim et al.
DRUG METABOLISM AND DISPOSITION (2008)
Pharmacogenetics of deoxycytidine kinase: Identification and characterization of novel genetic variants
Jatinder K. Lamba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides
Yoshio Endo et al.
CANCER SCIENCE (2007)
Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia
J. F. Mata et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers
M. Joerger et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1
Scott N. Myers et al.
PHARMACOGENETICS AND GENOMICS (2006)
Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter
SM Fitzgerald et al.
HUMAN GENETICS (2006)
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics
JA Gilbert et al.
CLINICAL CANCER RESEARCH (2006)
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
I Hubeek et al.
BRITISH JOURNAL OF CANCER (2005)
Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells
M Sarkar et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1
DH Osato et al.
PHARMACOGENETICS (2003)
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia
RW Stam et al.
BLOOD (2003)
A comparison of Bayesian methods for haplotype reconstruction from population genotype data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia
CM Galmarini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
